• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌

Thyroid cancer.

作者信息

Leeper R D

出版信息

Med Clin North Am. 1985 Sep;69(5):1079-96. doi: 10.1016/s0025-7125(16)31007-0.

DOI:10.1016/s0025-7125(16)31007-0
PMID:4058094
Abstract

Thyroid cancer encompasses some forms that practically have no identifiable mortality to one of the most lethal soft tissue cancers known. Because of this variation, a knowledge of the role that age, histology, and extent of disease play in establishing a prognosis is necessary to provide a rational therapeutic program. Younger patients (under age 40) with differentiated cancer, even those with lymph node metastases, should not be overtreated with extensive surgery and 131I or external beam therapy because the prognosis in these patients is so extremely good. Thyroid hormone suppression is probably adequate therapy for patients in this group after obvious disease has been resected. Recurrences can usually be effectively treated with 131I. On the other hand, older patients should be treated more aggressively, especially with the routine use of 131I ablation and therapy after resection of disease. Radiation therapy as described for recurrent disease should be considered at an early point and should be used immediately once the diagnosis of anaplastic cancer has been established. Finally, patience and observation alone should be considered a good therapeutic alternative, for example, in hypercalcitoninemic patients with medullary cancer that has been apparently adequately resected. Repeat operations in these patients fail to eliminate elevated serum calcitonin levels in the majority of cases, and the patients may live for many years with a good quality of life.

摘要

甲状腺癌涵盖了一些实际上没有可识别死亡率的类型,到已知的最致命的软组织癌之一。由于这种差异,了解年龄、组织学和疾病范围在确定预后中所起的作用对于提供合理的治疗方案是必要的。年轻患者(40岁以下)患有分化型癌,即使是那些有淋巴结转移的患者,也不应过度接受广泛手术、131I或外照射治疗,因为这些患者的预后非常好。对于这组患者,在切除明显疾病后,甲状腺激素抑制可能是足够的治疗方法。复发通常可用131I有效治疗。另一方面,老年患者应接受更积极的治疗,尤其是在疾病切除后常规使用131I消融和治疗。对于复发性疾病所描述的放射治疗应尽早考虑,一旦确诊为间变性癌,应立即使用。最后,仅耐心观察应被视为一种好的治疗选择,例如,对于已明显充分切除的髓样癌的高降钙素血症患者。在大多数情况下,这些患者的重复手术未能消除血清降钙素水平升高,并且患者可能以良好的生活质量存活多年。

相似文献

1
Thyroid cancer.甲状腺癌
Med Clin North Am. 1985 Sep;69(5):1079-96. doi: 10.1016/s0025-7125(16)31007-0.
2
[Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].[分化型甲状腺癌的诊断、治疗及随访]
Wien Med Wochenschr. 2005 Oct;155(19-20):429-35. doi: 10.1007/s10354-005-0219-8.
3
Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.锂剂作为低危甲状腺癌术后残余组织消融的辅助剂。
Thyroid. 2012 Oct;22(10):1002-6. doi: 10.1089/thy.2011.0372. Epub 2012 Sep 6.
4
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.在全甲状腺切除和放射性碘消融治疗后甲状腺癌分化型患者中,抗甲状腺球蛋白抗体阳性且甲状腺功能正常的患者随访期间血清促甲状腺激素升高时,诊断性全身扫描和血清甲状腺球蛋白的价值。
Thyroid. 2012 Feb;22(2):113-6. doi: 10.1089/thy.2011.0020. Epub 2012 Jan 6.
5
Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.甲状腺癌患者在进行消融性放射性碘治疗前甲状腺切除术后甲状腺球蛋白的预后价值。
J Nucl Med. 1996 Dec;37(12):1962-4.
6
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.初始手术和药物治疗对乳头状和滤泡状甲状腺癌的长期影响。
Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.
7
Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.治疗剂量的¹³¹I对甲状腺球蛋白水平升高且¹³¹I全身扫描阴性的甲状腺乳头状癌患者的影响:对比研究
Clin Endocrinol (Oxf). 2003 Apr;58(4):421-7. doi: 10.1046/j.1365-2265.2003.01733.x.
8
Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation.术后低水平非刺激甲状腺球蛋白作为避免放射性碘消融的标准。
Endocr Relat Cancer. 2016 Jan;23(1):47-52. doi: 10.1530/ERC-15-0458. Epub 2015 Oct 26.
9
Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.伴淋巴结转移的甲状腺乳头状癌术后复发
J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.
10
Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.对复发风险处于中等水平的甲状腺乳头状癌患者采用1.1吉贝可(30毫居里)碘-131进行甲状腺消融。
Thyroid. 2014 May;24(5):826-31. doi: 10.1089/thy.2013.0479. Epub 2014 Jan 24.

引用本文的文献

1
An Artificial Intelligence System for Optimizing Radioactive Iodine Therapy Dosimetry.一种用于优化放射性碘治疗剂量测定的人工智能系统。
J Clin Med. 2023 Dec 25;13(1):117. doi: 10.3390/jcm13010117.
2
Anaplastic thyroid carcinoma mimicking thyroid abscess.酷似甲状腺脓肿的间变性甲状腺癌。
AME Case Rep. 2018 May 6;2:20. doi: 10.21037/acr.2018.04.05. eCollection 2018.
3
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.儿童分化型甲状腺癌的治疗:重点关注手术方法和放射性碘治疗。
Endocr Rev. 2011 Dec;32(6):798-826. doi: 10.1210/er.2011-0011. Epub 2011 Aug 31.
4
Guidelines for radioiodine therapy of differentiated thyroid cancer.分化型甲状腺癌放射性碘治疗指南。
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59. doi: 10.1007/s00259-008-0883-1.